查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
激素替代疗法市场规模、份额和趋势分析：按产品（雌激素和黄体酮替代疗法）、给药途径、疾病类型、地区、细分市场预测，2022-2030
市场调查报告书
商品编码
1114019

激素替代疗法市场规模、份额和趋势分析：按产品（雌激素和黄体酮替代疗法）、给药途径、疾病类型、地区、细分市场预测，2022-2030

Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route Of Administration, By Disease Type, By Region, and Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 123 Pages | 商品交期: 2-10个工作天内

价格

激素替代疗法市场增长和趋势

根据 Grand View Research, Inc. 的一项新研究，到 2030 年，全球激素替代疗法市场预计将达到 357.9 亿美元。从 2022 年到 2030 年，它将以 6.4% 的复合年增长率增长。激素替代疗法市场的增长主要归因于激素疾病的流行率上升和药物输送系统的技术进步。根据国家罕见病组织的数据，美国大约有 70,000 人患有甲状旁腺功能减退症。

有望将副作用降至最低并提高药物生物利用度的技术进步将推动市场增长。增加的生物利用度增加了治疗频率。用于治疗生长激素缺乏症的 NGENLA 等产品仅需每週给药一次，这可以提高患者的依从性。此外，改进的给药途径有望推动产品的采用。例如，nafarelin 等鼻用雌激素製剂在女性中的依从性比传统方法更好。

公司通过合作、伙伴关係和协议来扩大影响范围并增加收入。例如，2021 年 9 月，默克公司与法国 BIOCORP 公司就 HGH 监测设备“Malya”的开发和销售达成协议。它用于监控和跟踪您的每日 HCG 治疗。预计此类策略将在预测期内推动市场增长。

此外，新的激素替代疗法药物进入市场也有望成为市场增长的驱动力。例如，2021年11月，富士药品株式会社宣布推出“F-memo（100mg胶囊）”，用于预防更年期障碍中雌激素製剂给药期间的子宫内膜增生。 F-memo是一种口服药物，被列入日本国民健康保险药品价格表。这些努力可能会提高激素替代治疗药物的处方率，并成为市场增长的驱动力。

然而，严重的副作用是市场增长的主要製约因素。 FDA 已在雌激素治疗中确定了某些药物，这些药物可能会导致副作用并增加女性患癌症的风险。辉瑞的 Premarin 和 Prepro 与癌症诱导有关。

激素替代疗法市场亮点

按产品划分，雌激素和孕激素替代疗法细分市场预计将在 2021 年占据市场主导地位，并在预测期内保持其主导地位，因为越来越多的女性经历了更年期的高需求

>

由于越来越多地采用激素替代疗法治疗甲状旁腺功能减退，预计甲状旁腺激素替代疗法在预测期内增长最快

从给药途径来看，由于处方率高，口服製剂将在 2021 年占据市场主导地位。美国每年大约开出 1.2 亿片左甲状腺素钠片

预计父母用药增长最快。预计长效产品的开发和批准将推动该领域的增长。例如，2021 年 10 月，辉瑞日本公司的每週一次的长效重组人生长激素药物 NGENLA (somatrogon) 获得加拿大卫生部的批准，用于治疗生长激素缺乏症患者。get

到 2021 年，随着 45-60 岁年龄组中更多的女性血管舒缩症状的发病率增加，可能导致骨质疏鬆症等严重疾病，预计更年期将发生。预计残疾疾病类型细分市场将主导市场并推动市场发展成长

目录

第1章调查方法及范围

  • 市场细分
    • 估计/预测时间表
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 辅助信息
    • 初步调查
    • 初步调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算国别市场
  • 全球市场：CAGR 计算
  • 调查假设
  • 辅助信息列表
  • 主要信息列表
  • 缩写列表
  • 目的
    • 目的 1
    • 目的 2
    • 目标 3
    • 目标 4

第 2 章执行摘要

  • 市场概况

第 3 章市场变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
  • 绘製渗透率和增长前景
  • 监管和报销框架
  • 市场变量分析
    • 市场驱动因素分析
      • 荷尔蒙失调的患病率不断上升，接受荷尔蒙替代疗法的患者人数不断增加
      • 给药系统技术开发
      • 加大研发投入，提高对激素缺乏症的认识
    • 市场约束分析
      • 昂贵的医疗费用
      • 副作用风险
  • 行业分析工具
    • 波特五力分析
  • 行业分析工具
    • PESTEL 分析
  • 管道分析

第 4 章激素替代疗法市场 - 细分分析，按产品类型，2018-2030 年（十亿美元）

  • HRT 市场：产品差异分析
  • 雌激素和孕激素替代疗法
    • 2018-2030 年雌激素和孕激素替代疗法市场（十亿美元）
  • 人类生长激素 (HGH) 替代疗法
    • 2018-2030 年 HGH 替代疗法市场（十亿美元）
  • 甲状腺激素替代疗法
    • 2018-2030 年甲状腺激素替代疗法市场（十亿美元）
  • 睪酮替代疗法
    • 2018-2030 年睪酮替代疗法市场（十亿美元）
  • 甲状旁腺激素替代疗法
    • 2018-2030 年甲状旁腺激素补充剂市场（十亿美元）

第 5 章激素替代疗法市场 - 细分分析，按管理途径，2018-2030 年（十亿美元）

  • HRT 市场：行政路径的变化分析
  • 口语
    • 2018-2030 年口腔市场（十亿美元）
  • 肠胃外
    • 2018-2030 年育儿市场（十亿美元）
  • 透皮
    • 2018-2030 年透皮市场（十亿美元）
  • 其他
    • 2018-2030 年其他市场（十亿美元）

第 6 章激素替代疗法市场 - 细分分析，按疾病类型，2018-2030 年（十亿美元）

  • HRT 市场：疾病类型的变异分析
  • 更年期
    • 2018-2030 年更年期市场（十亿美元）
  • 甲状腺功能减退
    • 2018-2030 年甲状腺功能减退市场（十亿美元）
  • 男性性腺机能减退
    • 2018-2030 年男性性腺功能减退症市场（十亿美元）
  • 生长激素缺乏症
    • 2018-2030 年生长激素缺乏症市场（十亿美元）
  • 甲状旁腺功能低下
    • 2018-2030 年甲状旁腺功能减退症（十亿美元）

第 7 章激素替代疗法市场 - 2018-2030 年各地区细分分析（十亿美元）

  • 2021 年和 2030 年激素替代疗法市场，按地区分列的市场份额
    • 北美
      • 2018-2030 年北美市场估计和预测（十亿美元）
      • 美国
      • 2018-2030 年美国市场估计和预测（十亿美元）
      • 加拿大
      • 2018-2030 年加拿大市场估计和预测（十亿美元）
    • 欧洲
      • 2018-2030 年欧洲市场估计和预测（十亿美元）
      • 英国
      • 2018-2030 年英国市场估计和预测（十亿美元）
      • 德国
      • 2018-2030 年德国市场估计和预测（十亿美元）
      • 法国
      • 2018-2030 年法国市场估计和预测（十亿美元）
      • 西班牙
      • 2018-2030 年西班牙市场估计和预测（十亿美元）
      • 意大利
      • 2018-2030 年意大利市场估计和预测（十亿美元）
    • 亚太地区
      • 2018-2030 年亚太市场估计和预测（十亿美元）
      • 日本
      • 2018-2030 年日本市场估计和预测（十亿美元）
      • 中国
      • 2018-2030 年中国市场估计和预测（十亿美元）
      • 印度
      • 2018-2030 年印度市场估计和预测（十亿美元）
      • 澳大利亚
      • 2018-2030 年澳大利亚市场估计和预测（十亿美元）
      • 韩国
      • 2018-2030 年韩国市场估计和预测（十亿美元）
    • 拉丁美洲
      • 2018-2030 年拉丁美洲市场估计和预测（十亿美元）
      • 巴西
      • 2018-2030 年巴西市场估计和预测（十亿美元）
      • 墨西哥
      • 2018-2030 年墨西哥市场估计和预测（十亿美元）
      • 阿根廷
      • 2018-2030 年阿根廷市场估计和预测（十亿美元）
    • 中东和非洲
      • 2018-2030 年中东和非洲市场估计和预测（十亿美元）
      • 南非
      • 2018-2030 年南非市场估计和预测（十亿美元）
      • 沙特阿拉伯
      • 2018-2030 年沙特阿拉伯市场估计和预测（十亿美元）
      • 阿拉伯联合酋长国
      • 2018-2030 年阿拉伯联合酋长国市场估计和预测（十亿美元）

第 8 章激素替代疗法市场 - 竞争分析

  • 分析重大交易和战略联盟
    • 推出新产品
    • 併购
    • 伙伴关係和战略合作
    • 会议和活动
  • 公司分类
    • 市场差异化因素
    • 创新者
    • 市场领导者
  • 供应商情况
    • 主要分销商和渠道合作伙伴列表
    • 主要客户
  • 热图分析
  • 上市公司
    • 2021 年主要参与者的市场份额分析
    • 公司市场分析
  • 私人公司
    • 主要初创公司列表
    • 本地网络地图
  • 公司简介
    • 拜耳公司
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • 辉瑞
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • 默克
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • 比阿特丽斯公司
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • 诺和诺德 A/S
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • 礼来公司
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • F. Hoffman-La Roche（基因泰克）
      • 公司概况
      • 财务表现
      • 产品基准
    • Noven Pharmaceuticals, Inc.
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
    • ASCEND Therapeutics USA, LLC.（Bethan Healthcare）
      • 公司概况
      • 产品基准
      • 战略举措
    • 艾伯维公司
      • 公司概况
      • 财务表现
      • 产品基准
      • 战略举措
Product Code: 978-1-68038-784-1

Hormone Replacement Therapy Market Growth & Trends:

The global hormone replacement therapy market is expected to reach USD 35.79 billion by 2030, according to a new study by Grand View Research, Inc. expanding at a CAGR of 6.4% from 2022 to 2030. The growth in the hormone replacement therapy market is largely attributable to the rising prevalence of hormonal disorders coupled with technological advancements in drug delivery systems. According to the National Organization of Rare Diseases, there are around 70,000 people with hypoparathyroidism in the U.S.

Technological advancements to minimize the side effects and enhance drug bioavailability are expected to boost the market growth. Due to better bioavailability, the treatment frequency increases. Products such as NGENLA, which is used to treat growth hormone deficiency, require a once-a-week dosage, which ensures better patient compliance. Furthermore, improvement in the route of administration is expected to boost the adoption of products. For instance, intranasal estrogen medication such as Nafarelin is comparatively more compliant in women than the conventional method.

Companies are taking initiatives such as collaboration, partnership, and agreement to expand their business footprint and generate revenue. For instance, in September 2021, Merck & Co., Inc. entered into an agreement with BIOCORP, a French company, for the development and distribution of the HGH monitoring device, Mallya. It is used to monitor and track daily HCG treatment. Such strategies are anticipated to propel the market growth during the forecast period.

Moreover, the launch of new hormone replacement therapy medicines in the market is anticipated to drive market growth. For instance, in November 2021, Fuji Pharma Co, Ltd. announced the launch of F-meno (100 mg capsule) for the prevention of endometrial hyperplasia on the administration of estrogen drugs for menopausal disorders. F-memo is an orally administered drug and is included in Japan's National Health Insurance Drug Price list. This initiative may boost the prescription rate for hormone replacement therapy drugs, thereby driving the market growth.

However, severe adverse effects act as key restraints for market growth. The FDA has identified certain drugs in estrogen therapy that can cause adverse reactions and increase the risk of cancer in women. Premarin and Prempro, manufactured by Pfizer, are found to be associated with inducing cancer.

Hormone Replacement Therapy Market Highlights:

  • Based on the product, the estrogen & progesterone replacement therapy segment dominated the market in 2021 and is estimated to maintain its dominance during the forecast period due to high demand due to the increasing number of women reaching menopause
  • Parathyroid hormone replacement therapy is anticipated to witness the fastest growth during the forecast period due to the rising adoption of hormone replacement for the treatment of hypoparathyroidism
  • Based on the route of administration, the oral segment dominated the market in 2021 owing to the high prescription rate. Around 120 million prescriptions of Levothyroxine sodium tablets are being dispensed annually in the U.S
  • Parenteral is expected to witness the fastest growth. The development and approval of long-acting products are expected to boost segment growth. For instance, in October 2021, Pfizer, Inc. received approval for its NGENLA (somatrogon), a once-a-week long-acting recombinant human growth hormone, from Health Canada for the treatment of a patient with growth hormone deficiency
  • Menopause disease type segment dominated the market in 2021 due to the rising number of women in the age group of 45 to 60 years and increasing incidence of vasomotor symptoms that may lead to severe conditions, such as osteoporosis, which are projected to fuel market growth

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 List of Abbreviations
  • 1.12 Objectives
    • 1.12.1 Objective 1
    • 1.12.2 Objective 2
    • 1.12.3 Objective 3
    • 1.12.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory and Reimbursement Framework
  • 3.4 Market Variable Analysis
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Rising prevalence of hormonal disorders and increasing number of patients undergoing hormone replacament therapy
      • 3.4.1.2 Technological developments in drug delivery systems
      • 3.4.1.3 Increasing R&D investments and rising awareness about hormone deficiency
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 High cost of treatment
      • 3.4.2.2 Risk of side effects
  • 3.5 Industry Analysis Tools
    • 3.5.1 Porter's five forces analysis
  • 3.6 Industry Analysis Tools
    • 3.6.1 PESTEL Analysis
  • 3.7 Pipeline Analysis

Chapter 4 Hormone Replacement Therapy Market - Segment Analysis, by Product Type, 2018 - 2030 (USD Billion)

  • 4.1 HRT Market: Product Movement Analysis
  • 4.2 Estrogen & Progesterone Replacement Therapy
    • 4.2.1 Estrogen & Progesterone replacement therapy market, 2018 - 2030 (USD Billion)
  • 4.3 Human Growth Hormone (HGH) Replacement Therapy
    • 4.3.1 HGH replacement therapy market, 2018 - 2030 (USD Billion)
  • 4.4 Thyroid Hormone Replacement Therapy
    • 4.4.1 Thyroid hormone replacement therapy market, 2018 - 2030 (USD Billion)
  • 4.5 Testosterone Replacement Therapy
    • 4.5.1 Testosterone replacement therapy market, 2018 - 2030 (USD Billion)
  • 4.6 Parathyroid Hormone Replacement
    • 4.6.1 Parathyroid Hormone Replacement market, 2018 - 2030 (USD Billion)

Chapter 5 Hormone Replacement Therapy Market - Segment Analysis, by Route of Administration, 2018 - 2030 (USD Billion)

  • 5.1 HRT Market: Route of Administration Movement Analysis
  • 5.2 Oral
    • 5.2.1 Oral market, 2018 - 2030 (USD Billion)
  • 5.3 Parenteral
    • 5.3.1 Parenteral market, 2018 - 2030 (USD Billion)
  • 5.4 Transdermal
    • 5.4.1 Transdermal market, 2018 - 2030 (USD Billion)
  • 5.5 Others
    • 5.5.1 Others market, 2018 - 2030 (USD Billion)

Chapter 6 Hormone Replacement Therapy Market - Segment Analysis, by Disease Type, 2018 - 2030 (USD Billion)

  • 6.1 HRT Market: Disease Type Movement Analysis
  • 6.2 Menopause
    • 6.2.1 Menopause market, 2018 - 2030 (USD Billion)
  • 6.3 Hypothyroidism
    • 6.3.1 Hypothyroidism market, 2018 - 2030 (USD Billion)
  • 6.4 Male Hypogonadism
    • 6.4.1 Male Hypogonadism market, 2018 - 2030 (USD Billion)
  • 6.5 Growth Hormone Deficiency
    • 6.5.1 Growth Hormone Deficiency market, 2018 - 2030 (USD Billion)
  • 6.6 Hypoparathyroidism
    • 6.6.1 Hypoparathyroidism, 2018 - 2030 (USD Billion)

Chapter 7 Hormone Replacement Therapy Market - Segment Analysis, By Region, 2018 - 2030 (USD Billion)

  • 7.1 Hormone Replacement Therapy Market, Market Share by Region, 2021 & 2030
    • 7.1.1 North America
      • 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.1.2 U.S.
      • 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.1.3 Canada
      • 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2 Europe
      • 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.2 UK
      • 7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.3 Germany
      • 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.4 France
      • 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.5 Spain
      • 7.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.6 Italy
      • 7.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3 Asia-Pacific
      • 7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.2 Japan
      • 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.3 China
      • 7.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.4 India
      • 7.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.5 Australia
      • 7.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.6 South Korea
      • 7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.4 Latin America
      • 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.2 Brazil
      • 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.3 Mexico
      • 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.4 Argentina
      • 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.5 Middle East and Africa
      • 7.1.5.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.2 South Africa
      • 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.3 Saudi Arabia
      • 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.4 UAE
      • 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 8 Hormone Replacement Therapy Market - Competitive Analysis

  • 8.1 Major Deals and Strategic Alliances Analysis
    • 8.1.1 New Product Launch
    • 8.1.2 Mergers and Acquisitions
    • 8.1.3 Partnerships and Strategic Collaborations
    • 8.1.4 Conferences and Campaigns
  • 8.2 Company Categorization
    • 8.2.1 Market Differentiators
    • 8.2.2 Innovators
    • 8.2.3 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List of key distributors and channel partners
    • 8.3.2 Key customers
  • 8.4 Heat map analysis
  • 8.5 Public Companies
    • 8.5.1 Key company market share analysis, 2021
    • 8.5.2 Company Market Position Analysis
  • 8.6 Private Companies
    • 8.6.1 List of key emerging companies
    • 8.6.2 Regional Network Map
  • 8.7 Company Profiles
    • 8.7.1 Bayer AG
      • 8.7.1.1 Company overview
      • 8.7.1.2 Financial performance
      • 8.7.1.3 Product benchmarking
      • 8.7.1.4 Strategic initiatives
    • 8.7.2 Pfizer, Inc.
      • 8.7.2.1 Company overview
      • 8.7.2.2 Financial performance
      • 8.7.2.3 Product benchmarking
      • 8.7.2.4 Strategic initiatives
    • 8.7.3 Merck & Co., Inc.
      • 8.7.3.1 Company overview
      • 8.7.3.2 Financial performance
      • 8.7.3.3 Product benchmarking
      • 8.7.3.4 Strategic initiatives
    • 8.7.4 Viatris Inc.
      • 8.7.4.1 Company overview
      • 8.7.4.2 Financial performance
      • 8.7.4.3 Product benchmarking
      • 8.7.4.4 Strategic initiatives
    • 8.7.5 Novo Nordisk A/S
      • 8.7.5.1 Company overview
      • 8.7.5.2 Financial performance
      • 8.7.5.3 Product benchmarking
      • 8.7.5.4 Strategic initiatives
    • 8.7.6 Eli Lilly and Company
      • 8.7.6.1 Company overview
      • 8.7.6.2 Financial performance
      • 8.7.6.3 Product benchmarking
      • 8.7.6.4 Strategic initiatives
    • 8.7.7 F. Hoffmann-La Roche Ltd. (Genentech)
      • 8.7.7.1 Company overview
      • 8.7.7.2 Financial performance
      • 8.7.7.3 Product benchmarking
    • 8.7.8 Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
      • 8.7.8.1 Company overview
      • 8.7.8.2 Financial performance
      • 8.7.8.3 Product benchmarking
      • 8.7.8.4 Strategic initiatives
    • 8.7.9 ASCEND Therapeutics US, LLC. (Besins Healthcare)
      • 8.7.9.1 Company overview
      • 8.7.9.2 Product benchmarking
      • 8.7.9.3 Strategic initiatives
    • 8.7.10 AbbVie Inc.
      • 8.7.10.1 Company overview
      • 8.7.10.2 Financial performance
      • 8.7.10.3 Product benchmarking
      • 8.7.10.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Regulatory framework
  • Table 4 Leading market players anticipated witnessing the highest growth
  • Table 5 List of key distributors and compounding pharmacies
  • Table 6 North America hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 7 North America hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 8 North America hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 9 U.S. hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 10 U.S. hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 11 U.S. hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 12 Canada hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 13 Canada hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 14 Canada hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 15 Europe hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 16 Europe hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 17 Europe hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 18 UK hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 19 UK hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 20 UK hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 21 Germany hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 22 Germany hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 23 Germany hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 24 France hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 25 France hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 26 France hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 27 Italy hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 28 Italy hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 29 Italy hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 30 Spain hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 31 Spain hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 32 Spain hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 33 Asia Pacific hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 36 Japan hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 37 Japan hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 38 Japan hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 39 China hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 40 China hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 41 China hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 42 India hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 43 India hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 44 India hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 45 Australia hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 46 Australia hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 47 Australia hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 48 South Korea hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 49 South Korea hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 50 South Korea hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 51 Latin America hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 52 Latin America hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 53 Latin America hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 54 Brazil hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 55 Brazil hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 56 Brazil hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 57 Mexico hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 58 Mexico hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 59 Mexico hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 60 Argentina hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 61 Argentina hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 62 Argentina hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 63 Middle East & Africa hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 64 Middle East & Africa hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 65 Middle East & Africa hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 66 South Africa hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 67 South Africa hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 68 South Africa hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 59 Saudi Arabia hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 70 Saudi Arabia hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 71 Saudi Arabia hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 72 UAE hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 73 UAE hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 74 UAE hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Hormone Replacement Therapy Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Market Summary
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 Market Driver Impact Analysis (Current & future impact)
  • Fig. 12 Market restraint impact analysis (Current & future impact)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 HRT market product outlook: Key takeaways
  • Fig. 16 Estrogen & progesterone replacement therapy market, 2018 - 2030 (USD Million)
  • Fig. 17 HGH replacement therapy market, 2018 - 2030 (USD Million)
  • Fig. 18 Thyroid hormone replacement therapy market, 2018 - 2030 (USD Million)
  • Fig. 19 Testosterone replacement therapy market, 2018 - 2030 (USD Million)
  • Fig. 20 Parathyroid hormone market, 2018 - 2030 (USD Million)
  • Fig. 21 HRT market route of administration outlook: Key takeaways
  • Fig. 22 HRT market: Route of administration movement analysis
  • Fig. 23 Oral market, 2018 - 2030 (USD Million)
  • Fig. 24 Parenteral market, 2018 - 2030 (USD Million)
  • Fig. 25 Transdermal market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 HRT market disease type outlook: Key takeaways
  • Fig. 28 HRT market: Disease type movement analysis
  • Fig. 29 Menopause market, 2018 - 2030 (USD Million)
  • Fig. 30 Hypothyroidism market, 2018 - 2030 (USD Million)
  • Fig. 31 Male hypogonadism market, 2018 - 2030 (USD Million)
  • Fig. 32 Growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 33 Hypoparathyroidism, 2018 - 2030 (USD Million)
  • Fig. 34 HRT Regional Outlook
  • Fig. 35 Regional outlook, 2021 & 2030
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 U.S.
  • Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Canada
  • Fig. 41 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Europe
  • Fig. 43 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 UK
  • Fig. 45 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Germany
  • Fig. 47 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 France
  • Fig. 49 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Spain
  • Fig. 51 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Italy
  • Fig. 53 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Asia-Pacific
  • Fig. 55 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Japan
  • Fig. 57 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 China
  • Fig. 59 China. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 India
  • Fig. 61 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Australia
  • Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea
  • Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America
  • Fig. 67 Latin America. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil
  • Fig. 69 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Mexico
  • Fig. 71 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina
  • Fig. 73 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Middle East & Africa
  • Fig. 75 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa
  • Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia
  • Fig. 79 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 UAE
  • Fig. 81 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Market differentiators
  • Fig. 83 Heat Map Analysis
  • Fig. 84 Key company market share analysis, 2021
  • Fig. 85 Company market position analysis
  • Fig. 86 Company market position analysis